RAPT Therapeutics (RAPT) Retained Earnings: 2020-2023
Historic Retained Earnings for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to -$484.7 million.
- Therapeutics' Retained Earnings fell 23.69% to -$561.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$561.3 million, marking a year-over-year decrease of 23.69%. This contributed to the annual value of -$484.7 million for FY2023, which is 31.75% down from last year.
- Per Therapeutics' latest filing, its Retained Earnings stood at -$484.7 million for FY2023, which was down 31.75% from -$367.9 million recorded in FY2022.
- In the past 5 years, Therapeutics' Retained Earnings ranged from a high of -$214.8 million in FY2020 and a low of -$484.7 million during FY2023.
- Its 3-year average for Retained Earnings is -$378.9 million, with a median of -$367.9 million in 2022.
- Data for Therapeutics' Retained Earnings shows a maximum YoY crashed of 32.21% (in 2021) over the last 5 years.
- Over the past 4 years, Therapeutics' Retained Earnings (Yearly) stood at -$214.8 million in 2020, then tumbled by 32.21% to -$284.0 million in 2021, then fell by 29.52% to -$367.9 million in 2022, then tumbled by 31.75% to -$484.7 million in 2023.